Success Item Removed From Cart

Basket Summary
Close

Your Cart is Empty

Subtotal
$0
Sales Tax
$0
Total
$0
Back to browsing

Insulin Like Growth Factor I Pipeline Drugs Market Overview

Insulin-like growth factor 1 (IGF-1) also called somatomedin C is a protein encoded by the IGF1 gene. It stimulates glucose transport in bone-derived osteoblastic (PyMS) cells and is effective at much lower concentrations than insulin. It plays a role in synapse maturation. It acts as a ligand for IGF1R. The Insulin Like Growth Factor I pipeline drugs market research report provides comprehensive information on the therapeutics under development for Fibroblast Growth Factor 2, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and the latest news and press releases.

Insulin Like Growth Factor I Pipeline Drugs Market Segmentation by Therapy Areas

The key therapy areas of the Insulin Like Growth Factor I pipeline drugs market are oncology, central nervous system, cardiovascular, metabolic disorders, musculoskeletal disorders, and ophthalmology.

Insulin Like Growth Factor I Pipeline Drugs Market Analysis, by Therapy Areas, 2022 (%)

Insulin Like Growth Factor I Pipeline Drugs Market Analysis, by Therapy Areas

For more therapy area insights into the Insulin Like Growth Factor I pipeline drugs market, download a free report sample

Insulin Like Growth Factor I Pipeline Drugs Market Segmentation by Mechanisms of Action

The key mechanisms of action of the Insulin Like Growth Factor I pipeline drugs market are Insulin Like Growth Factor I Inhibitor, and Insulin Like Growth Factor I Activator.

Insulin Like Growth Factor I Pipeline Drugs Market Analysis, by Mechanisms of Action, 2022 (%)

Insulin Like Growth Factor I Pipeline Drugs Market Analysis, by Mechanisms of Action

For more mechanisms of action insights into the Insulin Like Growth Factor I pipeline drugs market, download a free report sample

Insulin Like Growth Factor I Pipeline Drugs Market Segmentation by Routes of Administration

The key routes of administration in the Insulin Like Growth Factor I pipeline drugs market are intravenous, intramuscular, intravenous bolus, and ophthalmic.

Insulin Like Growth Factor I Pipeline Drugs Market Analysis, by Routes of Administration, 2022 (%)

Insulin Like Growth Factor I Pipeline Drugs Market Analysis, by Routes of Administration

For more routes of administration insights into the Insulin Like Growth Factor I pipeline drugs market, download a free report sample

Insulin Like Growth Factor I Pipeline Drugs Market Segmentation by Molecule Types

The key molecule types in the Insulin Like Growth Factor I pipeline drugs market are monoclonal antibody, synthetic peptide, cell therapy, gene therapy, peptide, and recombinant protein.

Insulin Like Growth Factor I Pipeline Drugs Market Analysis, by Molecule Types, 2022 (%)

Insulin Like Growth Factor I Pipeline Drugs Market Analysis, by Molecule Types

For more molecule type insights into the Insulin Like Growth Factor I pipeline drugs market, download a free report sample

Insulin Like Growth Factor I Pipeline Drugs Market - Competitive Landscape

Some of the leading companies in the Insulin Like Growth Factor I pipeline drugs market are Boehringer Ingelheim International GmbH, Genervon Biopharmaceuticals LLC, Helixmith Co Ltd, Regulaxis SAS, SIFI SpA, and Stem Cell Medicine Ltd.

Insulin Like Growth Factor I Pipeline Drugs Market Analysis, by Companies, 2022 (%)

Insulin Like Growth Factor I Pipeline Drugs Market Analysis, by Companies

To know more about the companies in the Insulin Like Growth Factor I pipeline drugs market, download a free report sample

Insulin Like Growth Factor I Pipeline Drugs Market Report Overview

Key Therapy Areas Oncology, Central Nervous System, Cardiovascular, Metabolic Disorders, Musculoskeletal Disorders, and Ophthalmology
Key Mechanisms of Action Insulin Like Growth Factor I Inhibitor, and Insulin Like Growth Factor I Activator
Key Routes of Administration Intravenous, Intramuscular, Intravenous Bolus, and Ophthalmic
Key Molecule Types Monoclonal Antibody, Synthetic Peptide, Cell Therapy, Gene Therapy, Peptide, and Recombinant Protein
Leading Companies Boehringer Ingelheim International GmbH, Genervon Biopharmaceuticals LLC, Helixmith Co Ltd, Regulaxis SAS, SIFI SpA, and Stem Cell Medicine Ltd

Segments Covered in the Report

Insulin Like Growth Factor I Pipeline Drugs Market Therapy Areas Outlook

  • Oncology
  • Central Nervous System
  • Cardiovascular
  • Metabolic Disorders
  • Musculoskeletal Disorders
  • Ophthalmology

Insulin Like Growth Factor I Pipeline Drugs Market Mechanisms of Action Outlook

  • Insulin Like Growth Factor I Inhibitor
  • Insulin Like Growth Factor I Activator

Insulin Like Growth Factor I Pipeline Drugs Market Routes of Administration Outlook

  • Intravenous
  • Intramuscular
  • Intravenous Bolus
  • Ophthalmic

Insulin Like Growth Factor I Pipeline Drugs Market Molecule Types Outlook

  • Monoclonal Antibody
  • Synthetic Peptide
  • Cell Therapy
  • Gene Therapy
  • Peptide
  • Recombinant Protein

Scope of Report

  • The report provides a snapshot of the global therapeutic landscape for Insulin Like Growth Factor I (Mechano Growth Factor or Somatomedin C or IGF1)
  • The report reviews Insulin Like Growth Factor I (Mechano Growth Factor or Somatomedin C or IGF1) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report reviews key players involved in Insulin Like Growth Factor I (Mechano Growth Factor or Somatomedin C or IGF1) targeted therapeutics and enlists all their major and minor projects
  • The report assesses Insulin Like Growth Factor I (Mechano Growth Factor or Somatomedin C or IGF1) targeted therapeutics based on mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report summarizes all the dormant and discontinued pipeline projects
  • The report reviews latest news and deals related to Insulin Like Growth Factor I (Mechano Growth Factor or Somatomedin C or IGF1) targeted therapeutics

Reasons to buy

  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand the targeted therapy areas and indications for Insulin Like Growth Factor I (Mechano Growth Factor or Somatomedin C or IGF1)Identify the use of drugs for target identification and drug repurposing
  • Identify potential new clients or partners in the target demographic
  • Develop strategic initiatives by understanding the focus areas of leading companies
  • Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding Insulin Like Growth Factor I (Mechano Growth Factor or Somatomedin C or IGF1) development landscape
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

FAQs

  • The key therapy areas in the Insulin Like Growth Factor I pipeline drugs market are oncology, central nervous system, cardiovascular, metabolic disorders, musculoskeletal disorders, and ophthalmology.

  • The key mechanisms of action in the Insulin Like Growth Factor I pipeline drugs market are Insulin Like Growth Factor I Inhibitor, and Insulin Like Growth Factor I Activator.

  • The key routes of administration in the Insulin Like Growth Factor I pipeline drugs market are intravenous, intramuscular, intravenous bolus, and ophthalmic.

  • The molecule types in the Insulin Like Growth Factor I pipeline drugs market are monoclonal antibody, synthetic peptide, cell therapy, gene therapy, peptide, and recombinant protein.

  • Some of the leading companies in the Insulin Like Growth Factor I pipeline drugs market are Boehringer Ingelheim International GmbH, Genervon Biopharmaceuticals LLC, Helixmith Co Ltd, Regulaxis SAS, SIFI SpA, and Stem Cell Medicine Ltd.

What our clients have to say

More Reports

View More Reports